Merck (MRK) shares down 2% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's
Go back to Merck (MRK) shares down 2% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer'sMerck & Co. (NYSE: MRK) | Delayed: 125.22 +0.16 (0.13%) | |||||
---|---|---|---|---|---|---|
Previous Close | $125.06 | 52 Week High | $65.46 | |||
Open | $125.67 | 52 Week Low | $47.97 | |||
Day High | $126.19 | P/E | 85.18 | |||
Day Low | $124.71 | EPS | $1.47 | |||
Volume | 3,921,663 |